Shopping Cart
Remove All
Your shopping cart is currently empty
Pegaptanib sodium, an RNA aptamer specifically targeting vascular endothelial growth factor (VEGF)-165, holds great promise for investigating neovascular age-related macular degeneration (AMD).

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 1 mg | Inquiry | Inquiry | Inquiry | |
| 5 mg | Inquiry | Inquiry | Inquiry | |
| 10 mg | Inquiry | Inquiry | Inquiry |
| Description | Pegaptanib sodium, an RNA aptamer specifically targeting vascular endothelial growth factor (VEGF)-165, holds great promise for investigating neovascular age-related macular degeneration (AMD). |
| In vitro | Pegaptanib impedes the VEGF165-induced phosphorylation of VEGFR2 and phospholipase Cγ, and also obstructs VEGF165-triggered calcium mobilization in human umbilical vein endothelial cells[1]. |
| Cas No. | 222716-86-1 |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.